ConductScience.org, home

Paper2804973

Enhancement of anthracycline growth inhibition in parent and multidrug-resistant Chinese hamster ovary cells by cyclosporin A and its analogues.

Chambers SK and 4 others. Cancer Res, 1989. Cited by 51 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Enhancement of anthracycline growth inhibition in parent and multidrug-resistant Chinese hamster ovary cells by cyclosporin A and its analogues. Papers, record 2804973. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2804973

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Enhancement of anthracycline growth inhibition in parent and multidrug-resistant Chinese hamster ovary cells by cyclosporin A and its analogues.
PubMed
Journal
Cancer Res
PubMed
Year
1989
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
51
iCite
Relative citation ratio, by iCite
1.57
iCite
Revised in PubMed
2013-11-21
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Chambers SKS K
2Hait WNW N
3Kacinski BMB M
4Keyes SRS R
5Handschumacher RER E

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Cell DivisionMajor topic
CyclosporinsMajor topic
DNA DamageMajor topic
DoxorubicinMajor topic
Animals
Cell Line
Cricetinae
Cricetulus
DNA, Single-Stranded
Drug Resistance
Epirubicin
Female
Kinetics
Ovary
Structure-Activity Relationship

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
CA 43888NCI NIH HHSUnited StatesR01CA043888PubMed and NIH

Source NIH RePORTER

Download CSV of grants

Cited by14

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 51 citations.

PMIDTitleJournalYearIn PapersSource
26688098Recapitulation of complex transport and action of drugs at the tumor microenvironment using tumor-microenvironment-on-chip.Cancer Lett2016https://conductscience.org/library/papers/26688098PubMed
24926353Resveratrol reverses multidrug resistance in human breast cancer doxorubicin-resistant cells.Exp Ther Med2014https://conductscience.org/library/papers/24926353PubMed
16925584Estrogen-mediated post transcriptional down-regulation of P-glycoprotein in MDR1-transduced human breast cancer cells.Cancer Sci2006https://conductscience.org/library/papers/16925584PubMed
8431967Modulation of drug cytotoxicity in wild-type and multidrug-resistant tumor cells by stereoisomeric series of C-20'-vinblastine congeners that lack antimicrotubule activity.Cancer Chemother Pharmacol1993https://conductscience.org/library/papers/8431967PubMed
8281626
Differential effectiveness of a range of novel drug-resistance modulators, relative to verapamil, in influencing vinblastine or teniposide cytotoxicity in human lymphoblastoid CCRF-CEM sublines expressing classic or atypical multidrug resistance.
Cancer Chemother Pharmacol1994https://conductscience.org/library/papers/8281626PubMed
8251651Expression of mdr1 gene in human breast primary tumors and metastases.Breast Cancer Res Treat1993https://conductscience.org/library/papers/8251651PubMed
8098047Sensitivity of K562 human chronic myelogenous leukemia blast cells transfected with a human multidrug resistance cDNA to cytotoxic drugs and differentiating agents.J Clin Invest1993https://conductscience.org/library/papers/8098047PubMed
7907333Secondary combined resistance to the multidrug-resistance-reversing activity of cyclosporin A in the cell line F4-6RADR-CsA.J Cancer Res Clin Oncol1994https://conductscience.org/library/papers/7907333PubMed
7773504Intracellular localization, vesicular accumulation and kinetics of daunorubicin in sensitive and multidrug-resistant gastric carcinoma EPG85-257 cells.Virchows Arch1995https://conductscience.org/library/papers/7773504PubMed
7765325Pharmacologic circumvention of multidrug resistance.Cytotechnology1993https://conductscience.org/library/papers/7765325PubMed
7635870Reversal of multidrug resistance by novel cyclosporin A analogues and the cyclopeptolide SDZ 214-103 biosynthesized in vitro.J Cancer Res Clin Oncol1995https://conductscience.org/library/papers/7635870PubMed
2390489Cyclosporin A and verapamil have different effects on energy metabolism in multidrug-resistant tumour cells.Br J Cancer1990https://conductscience.org/library/papers/2390489PubMed
1671752Reversal of intrinsic multidrug resistance in Chinese hamster ovary cells by amiloride analogs.Br J Cancer1991https://conductscience.org/library/papers/1671752PubMed
1313690Effects of cyclosporin A and a non-immunosuppressive analogue, O-acetyl cyclosporin A, upon the growth of parent and multidrug resistant human lung cancer cells in vitro.Br J Cancer1992https://conductscience.org/library/papers/1313690PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/2804973

GET https://conductscience.org/api/papers/v1/2804973/authors